Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Celldex receives Breakthrough Therapy Designation

The
Food and Drug Administration granted Breakthrough Therapy Designation
to Celldex Therapeutics Inc.’s (Nasdaq: CLDX) adult patients with
EGFRvIII-positive glioblastoma treatment rindopepimut. Shares of the biopharmaceutical leaped $3.52 to close at $24.73.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.